Landmark Huntington's trial starts.
The first drug that can potentially correct the underlying defect that causes Huntington's disease has been taken by patients in a clinical trial.
BBC.
Via: Bionews.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario